
15 Sep 2022
LIBERUM: Oxford Biomedica - In line interims as core offering builds
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
LIBERUM: Oxford Biomedica - In line interims as core offering builds
Oxford BioMedica plc (OXB:LON) | 592 35.6 1.0% | Mkt Cap: 712.2m
- Published:
15 Sep 2022 -
Author:
Edward Thomason -
Pages:
7 -